Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 252
Filter
1.
Int J Legal Med ; 132(2): 509-518, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29151120

ABSTRACT

Myocardial infarctions go along with biomechanical stress, i.e. stretching of muscle fibres, and the expression of certain marker molecules. We tested if two of those markers, endothelin-1 (ET-1) and growth differentiation factor 15 (GDF-15), can be used as immunohistochemical markers for myocardial ischaemia/infarctions. The study included experiments with an animal model, the isolated perfused Langendorff heart, as well as the investigation of human tissue samples drawn during autopsies. The overall picture of our results showed that GDF-15 is very sensitive and expressed very fast, not only as a consequence of ischaemia/infarctions, but also under other circumstances. Even an expression only caused by agony had to be discussed. ET-1, on the other hand, was less sensitive but only positive in those human cases with ischaemia/infarction that also showed typical alterations in conventional histology. Therefore, both markers did not proof to be a suitable diagnostic tool for myocardial infarctions. However, positive staining for ET-1 was also seen in rats' hearts that suffered from arrhythmias after electric shock and in the myocardium of the right ventricle in human control cases in which a right heart failure has to be discussed. Thus, especially ET-1 should be subject of further studies that focus on these pathologies.


Subject(s)
Endothelin-1/metabolism , Growth Differentiation Factor 15/metabolism , Myocardial Infarction/metabolism , Myocardium/metabolism , Animals , Biomarkers/metabolism , Case-Control Studies , Forensic Pathology , Humans , Immunohistochemistry , Models, Animal , Myocardial Reperfusion , Rats, Wistar , Staining and Labeling
3.
J Eur Acad Dermatol Venereol ; 31(9): 1468-1474, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28419674

ABSTRACT

BACKGROUND: Prognostic factors in patients with localized primary cutaneous malignant melanoma (CMM) are well described. However, prognostic factors for recurrence are less documented. OBJECTIVES: The aim of this study was to identify prognostic risk factors for first recurrence in patients with localized stages I-II CMM using population-based data. METHODS: This study included 1437 CMM patients registered in one region of Sweden during 1999-2012 follow-up through 31 December 2012. To identify first recurrence of CMM disease, data from a care data warehouse, the pathology and radiology department registries were used. Patients were also followed through a census register and the national Cause of Death Register. RESULTS: The 5- and 10-year recurrence-free survival (RFS) were 85.7% and 81.2%, respectively. The most common site of first recurrence was regional lymph node metastasis closely followed by distant metastasis. After adjusting for all prognostic factors, women had 50% lower risk of recurrence than men (HR = 0.5, 95% CI 0.4-0.7) and patients ≥70 had higher risk compared to patients 55-69 years (HR = 1.7, 95% CI 1.2-2.5). Other significant prognostic factors for risk of recurrence were tumour thickness, presence of ulceration, Clark's level of invasion and histogenetic type. CONCLUSION: Tumour thickness was found to be the predominant risk factor for recurrence. The prognostic factors for recurrence coincided with prognostic factors for CMM death. The most common site of first recurrence in stages I-II CMM is regional lymph node (42.8%) closely followed by distant metastases (37.6%), a fact which has to be taken into consideration when choosing follow-up strategies.


Subject(s)
Melanoma/pathology , Neoplasm Recurrence, Local , Registries , Skin Neoplasms/pathology , Aged , Disease-Free Survival , Female , Humans , Male , Melanoma/epidemiology , Middle Aged , Prognosis , Recurrence , Risk Factors , Skin Neoplasms/epidemiology , Sweden/epidemiology
4.
J Anim Physiol Anim Nutr (Berl) ; 101(4): 767-778, 2017 Aug.
Article in English | MEDLINE | ID: mdl-26959798

ABSTRACT

Herbage feeding with only little input of concentrates plays an important role in milk production in grassland dominated countries like Switzerland. The objective was to investigate the effects of a solely herbage-based diet and level of milk production on performance, and variables related to the metabolic, endocrine and inflammatory status to estimate the stress imposed on dairy cows. Twenty-five multiparous Holstein cows were divided into a control (C+, n = 13) and a treatment group (C-, n = 12), according to their previous lactation yield (4679-10 808 kg) from week 3 ante partum until week 8 post-partum (p.p.). While C+ received fresh herbage plus additional concentrate, no concentrate was fed to C- throughout the experiment. Within C+ and C-, the median of the preceding lactation yields (7752 kg) was used to split cows into a high (HYC+, HYC-)- and low-yielding (LYC+, LYC-) groups. Throughout the study, HYC+ had a higher milk yield (35.9 kg/d) compared to the other subgroups (27.2-31.7 kg/d, p < 0.05). Plasma glucose (3.51 vs. 3.72 mmol/l) and IGF-1 (66.0 vs. 78.9ng/mL) concentrations were lower in HYC-/LYC- compared to HYC+/LYC+ cows (p < 0.05). Plasma FFA and BHBA concentrations were dramatically elevated in HYC- (1.1 and 1.6 mmol/l) compared to all other subgroups (mean values: 0.5 and 0.6 mmol/l, p < 0.05). Saliva cortisol, plasma concentrations of serum amyloid A (SAA), haptoglobin (Hp), beta-endorphin (BE) and activity of alkaline phosphatase (AP) were not different between C+ and C-. In conclusion, herbage-fed high-yielding cows without supplementary concentrate experienced a high metabolic load resulting in a reduced performance compared to cows of similar potential fed accordingly. Low-yielding cows performed well without concentrate supplementation. Interestingly, the selected markers for inflammation and stress such as cortisol, Hp, SAA, BE and AP gave no indication for the metabolic load being translated into compromised well-being.


Subject(s)
Animal Feed/analysis , Cattle Diseases/blood , Cattle/physiology , Diet/veterinary , Energy Metabolism/physiology , Animal Nutritional Physiological Phenomena , Animals , Biomarkers/blood , Biomarkers/chemistry , Body Weight , Cattle/blood , Cattle Diseases/diagnosis , Milk/chemistry , Saliva/chemistry
5.
Int J Legal Med ; 130(4): 1053-1060, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27184659

ABSTRACT

The isolated Langendorff heart was used to evaluate dityrosine as a marker of acute myocardial infarctions. The animal model allowed the generation of local infarctions with defined survival times, as well as infarctions with and without reperfusion. The results showed that dityrosine, at least under the conditions of the animal model, occurs very shortly after early ischemia and infarctions, since positive staining results were already obtained after a survival time of only 5 min. Furthermore, it could be proved that the occurrence of dityrosine does not depend on a reperfusion of the ischemic muscle area and that there are no differences in the staining patterns of infarctions with and without reperfusion. Positive staining results for dityrosine in control hearts without infarctions had to be considered when evaluating the tissue samples of the study hearts. In part, the positive staining results of the control hearts seemed to be an artefact of the Langendorff system, easily identifiable by a distinctive staining pattern. Positive staining results in tissue samples of hearts that suffered from arrhythmia on the other hand implied that the occurrence of dityrosine is not specific for myocardial infarctions. Taking into account the results of previous works on human tissue samples, however, these findings did not question the use of dityrosine as a diagnostic tool; they simply showed that myocardial damage due to oxidative stress might occur under various pathologic conditions.


Subject(s)
Myocardial Infarction/diagnosis , Myocardium/metabolism , Tyrosine/analogs & derivatives , Animals , Biomarkers/metabolism , Disease Models, Animal , Immunohistochemistry , Isolated Heart Preparation , Myocardial Infarction/metabolism , Rats, Wistar , Tyrosine/metabolism
6.
Scand J Prim Health Care ; 34(1): 21-7, 2016.
Article in English | MEDLINE | ID: mdl-26849394

ABSTRACT

OBJECTIVES: To investigate the diagnostic value of different clinical and laboratory findings in pneumonia and to explore the association between the doctor's degree of suspicion and chest X-ray (CXR) result and to evaluate whether or not CXR should be used routinely in primary care, when available. DESIGN: A three-year prospective study was conducted between September 2011 and December 2014. SETTING: Two primary care settings in Linköping, Sweden. SUBJECTS: A total of 103 adult patients with suspected pneumonia in primary care. MAIN OUTCOME MEASURES: The physicians recorded results of a standardized medical physical examination, including laboratory results, and rated their suspicion into three degrees. The outcome of the diagnostic variables and the degree of suspicion was compared with the result of CXR. RESULTS: Radiographic pneumonia was reported in 45% of patients. When the physicians were sure of the diagnosis radiographic pneumonia was found in 88% of cases (p < 0.001), when quite sure the frequency of positive CXR was 45%, and when not sure 28%. Elevated levels of C-reactive protein (CRP) ≥ 50mg/L were associated with the presence of radiographic pneumonia when the diagnosis was suspected (p < 0.001). CONCLUSION: This study indicates that CXR can be useful if the physician is not sure of the diagnosis, but when sure one can rely on one's judgement without ordering CXR. KEY POINTS: There are different guidelines but no consensus on how to manage community-acquired pneumonia in primary care. When the physician is sure of the diagnosis the judgement is reliable without chest X-ray and antibiotics can be safely prescribed. Chest X-ray can be useful in the assessment of pneumonia in primary care, when the physician is not sure of the diagnosis.


Subject(s)
C-Reactive Protein/metabolism , Clinical Decision-Making/methods , Community-Acquired Infections/diagnosis , Pneumonia/diagnosis , Primary Health Care , Radiography, Thoracic/methods , Anti-Bacterial Agents/therapeutic use , Clinical Competence , Community-Acquired Infections/diagnostic imaging , Female , Humans , Judgment , Male , Middle Aged , Pneumonia/diagnostic imaging , Prospective Studies , Sweden , Uncertainty
7.
J Dairy Sci ; 99(3): 1951-1955, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26723129

ABSTRACT

Subacute ruminal acidosis is one of the most important digestive disorders in high-yielding dairy cows fed highly fermentable diets. Monitoring of forestomach pH has been suggested as a potentially valuable tool for diagnosing subacute ruminal acidosis. The objective of the present study was to compare continuously recorded measurements of an indwelling telemetric pH sensor inserted orally in the reticulum with those obtained from a measurement system placed in the ventral sac of the rumen through a cannula. The experiment was conducted with 6 ruminally cannulated Holstein cows kept in a freestall barn. Equal numbers of cows were assigned to 2 treatment groups based on their previous lactation milk yield. Cows in treatment CON- were offered a diet consisting of only fresh herbage cut once daily, and cows in treatment CON+ got fresh herbage plus a concentrate supplement according to the individual milk yield of each cow to meet their predicted nutrient requirements. The experiment lasted from 2 wk before the predicted calving date until wk 8 of lactation. During the whole experiment, a pH value was recorded every 10 min in the reticulum using a wireless telemetry bolus including a pH sensor (eBolus, eCow Ltd., Exeter, Devon, UK), which had been applied orally using a balling gun. Simultaneously, in wk 2, before the estimated calving date and in wk 2, 4, 6, and 8 of lactation, the ruminal pH was measured every 30 s for 48 h with the LRCpH measurement system (Dascor Inc., Escondido, CA) placed in the ventral sac of the rumen through the cannula. The readings of the LRCpH measurement system were summarized as an average over 10 min for statistical analysis. The recorded pH values were on average 0.24 pH units higher in the reticulum than in the rumen. The reticular pH also showed less fluctuation (overall SD 0.19 pH units) than pH profiles recorded in the rumen (overall SD 0.51 pH units). Regardless of measurement system, pH was not influenced by treatment, but varied across week of lactation and decreased with advancing lactation. The difference between ruminal and reticular pH varied across week of lactation. Due to this variation, no fixed conversion factor can be provided to make pH measurements in the reticulum comparable with those in the rumen.


Subject(s)
Cattle/physiology , Dairying/methods , Reticulum/chemistry , Rumen/chemistry , Animals , Dairying/instrumentation , Diet/veterinary , Female , Hydrogen-Ion Concentration , Lactation
8.
Ann Oncol ; 26(6): 1134-1142, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25722382

ABSTRACT

BACKGROUND: Tecemotide is a MUC1-antigen-specific cancer immunotherapy. The phase III START study did not meet its primary end point but reported notable survival benefit with tecemotide versus placebo in an exploratory analysis of the predefined patient subgroup treated with concurrent chemoradiotherapy. Here, we attempted to gain further insight into the effects of tecemotide in START. PATIENTS AND METHODS: START recruited patients who did not progress following frontline chemoradiotherapy for unresectable stage III non-small-cell lung cancer. We present updated overall survival (OS) data and exploratory analyses of OS for baseline biomarkers: soluble MUC1 (sMUC1), antinuclear antibodies (ANA), neutrophil/lymphocyte ratio (NLR), lymphocyte count, and HLA type. RESULTS: Updated OS data are consistent with the primary analysis: median 25.8 months (tecemotide) versus 22.4 months (placebo) (HR 0.89, 95% CI 0.77-1.03, P = 0.111), with ∼20 months additional median follow-up time compared with the primary analysis. Exploratory analysis of the predefined subgroup treated with concurrent chemoradiotherapy revealed clinically relevant prolonged OS with tecemotide versus placebo (29.4 versus 20.8 months; HR 0.81, 95% CI 0.68-0.98, P = 0.026). No improvement was seen with sequential chemoradiotherapy. High sMUC1 and ANA correlated with a possible survival benefit with tecemotide (interaction P = 0.0085 and 0.0022) and might have future value as biomarkers. Interactions between lymphocyte count, NLR, or prespecified HLA alleles and treatment effect were not observed. CONCLUSION: Updated OS data support potential treatment benefit with tecemotide in patients treated with concurrent chemoradiotherapy. Exploratory biomarker analyses suggest that elevated sMUC1 or ANA levels correlate with tecemotide benefit. CLINICALTRIALSGOV NUMBER: NCT00409188.


Subject(s)
Biomarkers, Tumor/blood , Cancer Vaccines/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Membrane Glycoproteins/therapeutic use , Mucin-1/blood , Adult , Aged , Aged, 80 and over , Antibodies, Antinuclear/blood , Cancer Vaccines/adverse effects , Carcinoma, Non-Small-Cell Lung/blood , Carcinoma, Non-Small-Cell Lung/immunology , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Chemoradiotherapy, Adjuvant , Female , Humans , Kaplan-Meier Estimate , Lung Neoplasms/blood , Lung Neoplasms/immunology , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lymphocyte Count , Male , Membrane Glycoproteins/adverse effects , Middle Aged , Mucin-1/immunology , Neutrophils , Predictive Value of Tests , Proportional Hazards Models , Risk Factors , Time Factors , Treatment Outcome , Young Adult
9.
Skin Res Technol ; 21(4): 493-9, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25773339

ABSTRACT

BACKGROUND/PURPOSE: The global incidence of skin cancer has increased drastically in recent decades, especially in Australia and Northern Europe. Early detection is crucial for good prognosis and high survival rates. In general, primary care physicians have considerably lower sensitivity and specificity rates for detection of skin cancer, compared to dermatologists. A probable main reason for this is that current diagnostic tools are subjective in nature, and therefore diagnostic skills highly depend on experience. Illustratively, in Sweden, approximately 155 500 benign skin lesions are excised unnecessarily every year. An objective instrument, added to the clinical examination, might improve the diagnostic accuracy, and thus promote earlier detection of malignant skin tumours, as well as reduce medical costs associated with unnecessary biopsies and excisions. The general aim of this study was to investigate the usefulness of the combination of near infrared (NIR) and skin impedance spectroscopy as a supportive tool in the diagnosis and evaluation of skin tumours in primary health care. METHODS: Near infrared and skin impedance data were collected by performing measurements on suspect malignant, premalignant and benign tumours in the skin of patients seeking primary health care for skin tumour evaluation. The obtained data were analysed using multivariate analysis and compared with the diagnosis received by the conventional diagnostic process. RESULTS: The observed sensitivity and specificity rates were both 100%, when discriminating malignant and premalignant skin tumours from benign skin tumours, and the observed sensitivity and specificity for separating malignant skin tumours from premalignant and benign skin tumours were also 100%, respectively. CONCLUSION: The results of this study indicate that the NIR and skin impedance spectroscopy may be a useful supportive tool for the general practitioner in the diagnosis and evaluation of skin tumours in primary health care, as a complement to the visual assessment.


Subject(s)
Diagnosis, Computer-Assisted/methods , Dielectric Spectroscopy/methods , Early Detection of Cancer/methods , Skin Neoplasms/diagnosis , Spectroscopy, Near-Infrared/methods , Adult , Aged , Aged, 80 and over , Feasibility Studies , Female , Humans , Male , Middle Aged , Multivariate Analysis , Observer Variation , Primary Health Care , Reproducibility of Results , Sensitivity and Specificity
10.
Am J Physiol Renal Physiol ; 307(10): F1105-10, 2014 Nov 15.
Article in English | MEDLINE | ID: mdl-25186294

ABSTRACT

Indomethacin and ibuprofen are administered to close a patent ductus arteriosus (PDA) during active glomerulogenesis. Light and electron microscopic glomerular changes with no change in glomerular number were seen following indomethacin and ibuprofen treatment during glomerulogenesis at 14 days after birth in a neonatal rat model. This present study aimed to determine whether longstanding renal structural changes are present at 30 days and 6 mo (equivalent to human adulthood). Rat pups were administered indomethacin or ibuprofen antenatally on days 18-20 (0.5 mg·kg(-1)·dose(-1) indomethacin; 10 mg·kg(-1)·dose(-1) ibuprofen) or postnatally intraperitoneally from day 1 to 3 or day 1 to 5 (0.2 mg·kg(-1)·dose(-1) indomethacin; 10 mg·kg(-1)·dose(-1) ibuprofen). Control groups received no treatment or normal saline intraperitoneally. Pups were killed at 30 days of age and 6 mo of age. Tissue blocks from right kidneys were prepared for light and electron microscopic examination, while total glomerular number was determined in left kidneys using unbiased stereology. Eight pups were included in each group from 14 maternal rats. At 30 days and 6 mo, there were persistent electron microscopy abnormalities of the glomerular basement membrane in those receiving postnatal indomethacin and ibuprofen. There were no significant light microscopy findings at 30 days or 6 mo. At 6 mo, there were significantly fewer glomeruli in those receiving postnatal indomethacin but not ibuprofen (P = 0.003). In conclusion, indomethacin administered during glomerulogenesis appears to reduce the number of glomeruli in adulthood. Alternative options for closing a PDA should be considered including ibuprofen as well as emerging therapies such as paracetamol.


Subject(s)
Cyclooxygenase Inhibitors/adverse effects , Ibuprofen/adverse effects , Indomethacin/adverse effects , Kidney Glomerulus/drug effects , Tocolytic Agents/adverse effects , Animals , Animals, Newborn , Body Weight/drug effects , Female , Kidney Glomerulus/embryology , Kidney Glomerulus/ultrastructure , Pregnancy , Rats, Sprague-Dawley
11.
Folia Biol (Praha) ; 60 Suppl 1: 1-7, 2014.
Article in English | MEDLINE | ID: mdl-25369334

ABSTRACT

Myelodysplastic syndromes (MDS) represent a clinically and genetically heterogeneous group of clonal haematopoietic diseases characterized by a short survival and high rate of transformation to acute myeloid leukaemia (AML). In spite of this variability, MDS is associated with typical recurrent non-random cytogenetic defects. Chromosomal abnormalities are detected in the malignant bone-marrow cells of approximately 40-80 % of patients with primary or secondary MDS. The most frequent chromosomal rearrangements involve chromosomes 5, 7 and 8. MDS often shows presence of unbalanced chromosomal changes, especially large deletions [del(5), del(7q), del(12p), del(18q), del(20q)] or losses of whole chromosomes (7 and Y). The most typical cytogenetic abnormality is a partial or complete deletion of 5q- that occurs in roughly 30 % of all MDS cases either as the sole abnormality or in combination with other aberrations as a part of frequently complex karyotypes. The mechanisms responsible for the formation of MDS-associated recurrent translocations and complex karyotypes are unknown. Since some of the mentioned aberrations are characteristic for several haematological malignancies, more general cellular conditions could be expected to play a role. In this article, we introduce the most common rearrangements linked to MDS and discuss the potential role of the non-random higher-order chromatin structure in their formation. A contribution of the chromothripsis - a catastrophic event discovered only recently - is considered to explain how complex karyotypes may occur (during a single event).


Subject(s)
Chromatin/metabolism , Chromosome Aberrations , Gene Rearrangement , Myelodysplastic Syndromes/genetics , Humans
12.
Phys Rev E ; 109(5): L053002, 2024 May.
Article in English | MEDLINE | ID: mdl-38907479

ABSTRACT

In amorphous materials, plasticity is localized and occurs as shear transformations. It was recently shown by Wu et al. that these shear transformations can be predicted by applying topological defect concepts developed for liquid crystals to an analysis of vibrational eigenmodes [Z. W. Wu et al., Nat. Commun. 14, 2955 (2023)10.1038/s41467-023-38547-w]. This study relates the -1 topological defects to the displacement fields expected of an Eshelby inclusion, which are characterized by an orientation and the magnitude of the eigenstrain. A corresponding orientation and magnitude can be defined for each defect using the local displacement field around each defect. These parameters characterize the plastic stress relaxation associated with the local structural rearrangement and can be extracted using the fit to either the global displacement field or the local field. Both methods provide a reasonable estimation of the molecular-dynamics-measured stress drop, confirming the localized nature of the displacements that control both long-range deformation and stress relaxation.

13.
AJNR Am J Neuroradiol ; 44(5): 602-610, 2023 05.
Article in English | MEDLINE | ID: mdl-37024306

ABSTRACT

BACKGROUND AND PURPOSE: An increased number of pathogenic variants have been described in mitochondrial encephalomyopathy lactic acidosis and strokelike episodes (MELAS). Different imaging presentations have emerged in parallel with a growing recognition of clinical and outcome variability, which pose a diagnostic challenge to neurologists and radiologists and may impact an individual patient's response to therapeutic interventions. By evaluating clinical, neuroimaging, laboratory, and genetic findings, we sought to improve our understanding of the sources of potential phenotype variability in patients with MELAS. MATERIALS AND METHODS: This retrospective single-center study included individuals who had confirmed mitochondrial DNA pathogenic variants and a diagnosis of MELAS and whose data were reviewed from January 2000 through November 2021. The approach included a review of clinical, neuroimaging, laboratory, and genetic data, followed by an unsupervised hierarchical cluster analysis looking for sources of phenotype variability in MELAS. Subsequently, experts identified "victory-variables" that best differentiated MELAS cohort clusters. RESULTS: Thirty-five patients with a diagnosis of mitochondrial DNA-based MELAS (median age, 12 years; interquartile range, 7-24 years; 24 female) were eligible for this study. Fifty-three discrete variables were evaluated by an unsupervised cluster analysis, which revealed that two distinct phenotypes exist among patients with MELAS. After experts reviewed the variables, they selected 8 victory-variables with the greatest impact in determining the MELAS subgroups: developmental delay, sensorineural hearing loss, vision loss in the first strokelike episode, Leigh syndrome overlap, age at the first strokelike episode, cortical lesion size, regional brain distribution of lesions, and genetic groups. Ultimately, 2-step differentiating criteria were defined to classify atypical MELAS. CONCLUSIONS: We identified 2 distinct patterns of MELAS: classic MELAS and atypical MELAS. Recognizing different patterns in MELAS presentations will enable clinical and research care teams to better understand the natural history and prognosis of MELAS and identify the best candidates for specific therapeutic interventions.


Subject(s)
Acidosis, Lactic , MELAS Syndrome , Stroke , Female , Humans , MELAS Syndrome/diagnosis , MELAS Syndrome/genetics , MELAS Syndrome/pathology , Retrospective Studies , DNA, Mitochondrial/genetics , Phenotype
14.
J Am Chem Soc ; 133(28): 10692-5, 2011 Jul 20.
Article in English | MEDLINE | ID: mdl-21707081

ABSTRACT

The reduction of a single-layer FeO film grown on Pt(111) by CO at elevated pressures and temperatures has been studied through an interplay of scanning tunneling microscopy, ambient-pressure X-ray photoelectron spectroscopy, and density functional theory calculations. Exposure of the FeO thin film to CO at pressures between 1 and 30 Torr and temperatures between 500 and 530 K leads to formation of a honeycomb-structured Fe(3)O(2) film with hollow sites occupied by single Pt atoms extracted from the substrate surface. The formation of these adatoms is driven by an increase in CO adsorption energy. In addition, the structure incorporates undercoordinated Fe centers, which are proposed to have substantial effects on the catalytic properties of the surface.

15.
J Mater Sci Mater Med ; 22(5): 1195-203, 2011 May.
Article in English | MEDLINE | ID: mdl-21445655

ABSTRACT

Recently, nano-macro dual-porous, three-dimensional (3D) glass structures were developed for use as bioscaffolds for hard tissue regeneration, but there have been concerns regarding the interconnectivity and homogeneity of nanopores in the scaffolds, as well as the cytotoxicity of the environment deep inside due to limited fluid access. Therefore, mercury porosimetry, nitrogen absorption, and TEM have been used to characterize nanopore network of the scaffolds. In parallel, viability of MG 63 human osteosarcoma cells seeded on scaffold surface was investigated by fluorescence, confocal and electron microscopy methods. The results show that cells attach, migrate and penetrate inside the glass scaffold with high proliferation and viability rate. Additionally, scaffolds were implanted under the skin of a male New Zealand rabbit for in vivo animal test. Initial observations show the formation of new tissue with blood vessels and collagen fibers deep inside the implanted scaffolds with no obvious inflammatory reaction. Thus, the new nano-macro dual-porous glass structure could be a promising bioscaffold for use in regenerative medicine and tissue engineering for bone regeneration.


Subject(s)
Biocompatible Materials , Tissue Engineering/methods , Tissue Scaffolds , Animals , Bone Demineralization Technique , Calcium Compounds , Cell Line, Tumor , Male , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Nanostructures , Osteoblasts , Oxides , Rabbits , Silicon Dioxide
16.
Pathol Res Pract ; 227: 153651, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34673351

ABSTRACT

Immune related endonucleases have recently been described as potential therapeutic targets and predictors of response to treatment with immune checkpoint inhibitors (ICI). The aim is to evaluate the association between the expression of 5 biomarkers involved in the immune response (CD73, CD39, VISTA, Arl4d and Cytohesin-3) in parallel with the more common ICI-predictive markers, PD-L1 expression and Tumor Mutation Burden (TMB) with response to ICI therapy in an advanced non-small cell lung cancer (NSCLC) cohort. METHODS: Patients with advanced NSCLC treated with ICI single agent were divided into responders and non-responders according to RECIST v1.1 and duration of response (DOR) criteria. Immunohistochemistry was performed on pretreatment tumor tissue samples for PD-L1, CD73, CD39, VISTA, Arl4d, and Cytohesin-3 expression. TMB was estimated with NEOplus v2 RUO (NEO New Oncology GmbH) hybrid capture next generation sequencing assay. Resistance mutations in STK11/KEAP1 and positive predictive mutations in ARID1A/POLE were also evaluated. RESULTS: Included were 56 patients who were treated with ICI single agent. The median progression-free and overall survival for the whole cohort was 3.0 (95% CI, 2.4-3.6) and 15 (95% CI, 9.7-20.2) months, respectively. The distribution of CD73 in tumor cells and CD39, VISTA, Arl4d and Cytohesin-3 expression in immune cells were not different between responders and non-responders. Also, PD-L1 and TMB were not predictive for response. The frequency of STK11, KEAP1 and ARID1A mutations was low and only observed in the non-responder group. CONCLUSION: Separate and combined expression of 5 biomarkers involved in the immune response (CD73, CD39, VISTA, Arl4d, and Cytohesin-3) was not associated with response in our cohort of advanced NSCLC patients receiving single agent ICI. To confirm our findings the analysis of independent larger cohorts is warranted.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Biomarkers, Tumor/analysis , Carcinoma, Non-Small-Cell Lung/drug therapy , Immune Checkpoint Inhibitors/therapeutic use , Lung Neoplasms/drug therapy , Nivolumab/therapeutic use , 5'-Nucleotidase/analysis , ADP-Ribosylation Factors/analysis , Aged , Aged, 80 and over , Apyrase/analysis , B7 Antigens/analysis , Biomarkers, Tumor/genetics , Carcinoma, Non-Small-Cell Lung/enzymology , Carcinoma, Non-Small-Cell Lung/immunology , Carcinoma, Non-Small-Cell Lung/mortality , Disease Progression , Female , GPI-Linked Proteins/analysis , Humans , Immunohistochemistry , Lung Neoplasms/enzymology , Lung Neoplasms/immunology , Lung Neoplasms/mortality , Male , Middle Aged , Mutation , Predictive Value of Tests , Progression-Free Survival , Receptors, Cytoplasmic and Nuclear/analysis , Time Factors
17.
AJNR Am J Neuroradiol ; 42(2): 389-396, 2021 01.
Article in English | MEDLINE | ID: mdl-33384291

ABSTRACT

BACKGROUND AND PURPOSE: Little is known about imaging features of spinal cord lesions in mitochondrial disorders. The aim of this research was to assess the frequency, imaging features, and pathogenic variants causing primary mitochondrial disease in children with spinal cord lesions. MATERIALS AND METHODS: This retrospective analysis included patients seen at Children's Hospital of Philadelphia between 2000 and 2019 who had a confirmed diagnosis of a primary (genetic-based) mitochondrial disease and available MR imaging of the spine. The MR imaging included at least both sagittal and axial fast spin-echo T2-weighted images. Spine images were independently reviewed by 2 neuroradiologists. Location and imaging features of spinal cord lesions were correlated and tested using the Fisher exact test. RESULTS: Of 119 children with primary mitochondrial disease in whom MR imaging was available, only 33 of 119 (28%) had available spine imaging for reanalysis. Nineteen of these 33 individuals (58%) had evidence of spinal cord lesions. Two main patterns of spinal cord lesions were identified: group A (12/19; 63%) had white ± gray matter involvement, and group B (7/19; 37%) had isolated gray matter involvement. Group A spinal cord lesions were similar to those seen in patients with neuromyelitis optica spectrum disorder, multiple sclerosis, anti-myelin oligodendrocyte glycoprotein-IgG antibody disease, and leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Group B patients had spinal cord findings similar to those that occur with ischemia and viral infections. Significant associations were seen between the pattern of lesions (group A versus group B) and the location of lesions in cervical versus thoracolumbar segments, respectively (P < .01). CONCLUSIONS: Spinal cord lesions are frequently observed in children with primary mitochondrial disease and may mimic more common causes such as demyelination and ischemia.


Subject(s)
Mitochondrial Diseases/pathology , Neuroimaging/methods , Spinal Cord/diagnostic imaging , Spinal Cord/pathology , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Infant , Inflammation/diagnosis , Inflammation/pathology , Ischemia/diagnosis , Ischemia/pathology , Magnetic Resonance Imaging/methods , Male , Retrospective Studies , Spinal Cord Diseases/diagnosis , Spinal Cord Diseases/etiology , Spinal Cord Diseases/pathology
18.
Opt Lett ; 35(7): 1070-2, 2010 Apr 01.
Article in English | MEDLINE | ID: mdl-20364220

ABSTRACT

Absorption measurements on 5 mol. % MgO-doped and undoped congruent lithium niobate (LiNbO(3)) crystals revealed absorption bands in the wavelength range of 2500-2800 nm, caused by incorporated hydrogen ions. High-temperature annealing was applied to the congruent LiNbO(3) (CLN) crystals, which decreased the absorption significantly. Then the annealed CLN crystals were periodically poled. As an application of the low-loss annealed CLN crystal, the operation of a 1550 nm pumped singly resonant CW optical parametric oscillator, resonant around 2600 nm, using a periodically poled crystal was demonstrated.

19.
J Trace Elem Med Biol ; 58: 126439, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31830704

ABSTRACT

BACKGROUND: Studies in mammals proved dietary organic selenium (Se) being superior to inorganic Se regarding effects on growth performance, antioxidative status, immune response, and Se homeostasis. However, the picture of possible effects of different Se sources and - levels can be expanded. The present field study evaluated the effects on weight gain, hematological and selected biochemical variables as well as plasma concentrations of vitamin E (vitE), total Se and selenobiomolecules in piglets throughout the suckling period. METHODS: Piglets were monitored from birth to 38 days of age (d). The mother sows' diets were enriched with l-selenomethionine (SeMet-0.26 and -0.43 mg Se/kg feed) or sodium selenite (NaSe-0.40 and -0.60 mg Se/kg feed) from 1 month prior to farrowing until the end of lactation period. Piglets received pelleted feed supplemented with Se similarly to the sows' diets from one week of age. Selenite at 0.40 mg Se/kg (NaSe-0.40) represents a common Se source and -level in pig feed and served as control diet. RESULTS: From 24d, piglets in SeMet-groups had higher mean body weight (BW) compared with piglets from sows fed NaSe-0.40. Furthermore, from five-d and above, piglets from sows fed NaSe-0.60 had significantly higher BW than offspring from sows fed NaSe-0.40. Neonatal piglets in group SeMet-0.43 had significantly lower red blood cell counts (RBC), hemoglobin (Hgb) and hematocrit (Hct) concentrations compared with piglets from sows fed with NaSe-0.40. Neonatal and 5d-old piglets in group SeMet-0.26 showed higher gamma-glutamyl transferase activity than piglets in group NaSe-0.40. From five d and above, group NaSe-0.60 excelled with increased specific hematological variables culminating at age 38d with increased Hct, mean corpuscular volume (MCV), and MC hemoglobin (MCH) as well as increased activities of aspartate transaminase and lactate dehydrogenase compared with the other groups. Generally, offspring in the SeMet groups had higher total Se-concentrations in plasma than those from sows fed selenite, and showed a dose-response effect on plasma Se-concentrations. Furthermore, SeMet-fed piglets had higher plasma levels of the selenoproteins (Sel) glutathione peroxidase 3 (GPx3) and SelP as well as selenoalbumin. Plasma vitE levels were significantly negatively correlated with RBC throughout trial period. CONCLUSIONS: Maternal supplementation with SeMet during gestation influenced hematology and clinical biochemistry in neonatal piglets in a different way than in offspring from sows receiving selenite enriched diets. Growth performance was positively influenced by both dietary Se source and Se level. Higher plasma levels of GPx3 observed in piglets receiving SeMet probably improved the protection against birth or growth related oxidative stress. These might prime the piglets for demanding situations as indicated by higher weight gain in offspring from sows fed with SeMet-supplemented diets. Our results on some enzyme activities might indicate that piglets fed NaSe-0.60 had to cope with increased levels of oxidative stress compared with those originating from sows fed SeMet or lower dietary levels of selenite. We assume that combining inorganic and organic Se sources in complete feed for breeding sows might be beneficial fro reproduction and the offspring's performance.


Subject(s)
Antioxidants/metabolism , Feeding Behavior , Selenomethionine/pharmacology , Sodium Selenite/pharmacology , Animals , Animals, Newborn , Body Weight/drug effects , Diet/veterinary , Organ Specificity/drug effects , Selenium/blood , Swine/blood , Vitamin E/blood
20.
AJNR Am J Neuroradiol ; 41(5): 917-922, 2020 05.
Article in English | MEDLINE | ID: mdl-32381541

ABSTRACT

Pathogenic variants in the polymerase γ gene (POLG) cause a diverse group of pathologies known as POLG-related disorders. In this report, we describe brain MR imaging findings and electroencephalogram correlates of 13 children with POLG-related disorders at diagnosis and follow-up. At diagnosis, all patients had seizures and 12 had abnormal MR imaging findings. The most common imaging findings were unilateral or bilateral perirolandic (54%) and unilateral or bilateral thalamic signal changes (77%). Association of epilepsia partialis continua with perirolandic and thalamic signal changes was present in 86% and 70% of the patients, respectively. The occipital lobe was affected in 2 patients. On follow-up, 92% of the patients had disease progression or fatal outcome. Rapid volume loss was seen in 77% of the patients. The occipital lobe (61%) and thalamus (61%) were the most affected brain regions. Perirolandic signal changes and seizures may represent a brain imaging biomarker of early-onset pediatric POLG-related disorders.


Subject(s)
Brain/diagnostic imaging , Mitochondrial Diseases/diagnostic imaging , Neuroimaging/methods , Seizures/diagnostic imaging , Seizures/genetics , Brain/pathology , Child , Child, Preschool , DNA Polymerase gamma/genetics , Electroencephalography , Female , Humans , Magnetic Resonance Imaging , Male , Mitochondrial Diseases/genetics , Mitochondrial Diseases/pathology , Retrospective Studies , Seizures/pathology
SELECTION OF CITATIONS
SEARCH DETAIL